Dechane Pharmceutical Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.13 M
- Company Age 48 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -0.27%
- Ebitda -0.86%
- Net Worth -1.71%
- Total Assets -11.63%
About Dechane Pharmceutical
Dechane Pharmceutical Private Limited (DPPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 July 1976 and has a history of 48 years and seven months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Media And Publishing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.13 M, as per Ministry of Corporate Affairs (MCA) records.
Wilfred Desouza and Wendy Desouza serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U52520TG1976PTC002045
- Company No.
002045
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jul 1976
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Dechane Pharmceutical Private Limited offer?
Dechane Pharmceutical Private Limited offers a wide range of products and services, including Medicines, Cough Drops, Wpurif, Dried Ferrous Sulphate, Nutritional Supplements, Ferrous Fumarate Tablet, Ind Chem, Ferrous Sulphate, Ferrous Fumarate, Ferrous Bisglycinate.
Who are the key members and board of directors at Dechane Pharmceutical?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Wendy Desouza  | Managing Director | 28-Oct-2005 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Wilfred Desouza | Director | 18-May-2003 | Current |
Financial Performance of Dechane Pharmceutical.
Dechane Pharmceutical Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 0.27% decrease in profit. The company's net worth dipped by a decrease of 1.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dechane Pharmceutical?
In 2017, Dechane Pharmceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dechane Pharmceutical?
Unlock and access historical data on people associated with Dechane Pharmceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dechane Pharmceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dechane Pharmceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.